Tag: Therapy & Procedures: Misc.
Higher Tisagenlecleucel Doses May Improve Outcomes in Youth With B-ALL
Overall, event-free, relapse-free survival improved in patients receiving higher doses of tisagenlecleucel, with no increased toxicity
Marketing of Shockwave Therapy for Erectile Dysfunction Raises Concerns
Techniques, costs, and provider credentials in biggest U.S. cities vary widely
ACC: Lasting Reduction in BP Seen With Radiofrequency Renal Denervation
Significant reductions in systolic and diastolic BP observed at up to 36 months following intervention versus sham control procedure
Early Use of COVID-19 Convalescent Plasma Cuts Hospitalization Risk
Administration of convalescent plasma within nine days after symptom onset can reduce risk of COVID-19-linked hospitalization
Gene Therapy Potentially Curative for β-Thalassemia
Transfusion independence, near-normal Hb levels seen for most children and adults receiving beti-cel for non-β0/β0 genotype β-thalassemia
Enhanced External Counterpulsation Eases ‘Long COVID’
Improvements seen in symptoms of fatigue, breathing difficulties, 6-minute walk test with EECP treatment
Bridging Therapy May Be Better for Large Vessel Occlusion Stroke
Better outcomes associated with IV thrombolysis followed by mechanical thrombectomy versus mechanical thrombectomy alone
ASA: Endovascular Therapy Studied in Large Ischemic Stroke
Better functional outcomes but more intracranial hemorrhages seen with endovascular therapy plus medical care versus medical care alone
COVID-19 Convalescent Plasma Seems Safe for High-Risk Children
Recipient plasma neutralization titers were 6.2 percent of donor titers as early as 30 minutes after transfusion
COVID-19 Convalescent Plasma No Benefit for Most Patients
No association with clinical outcomes for typical patients; heterogeneity of treatment effect sizes seen across baseline characteristics
